Dallas, Texa (PRWEB) July 20, 2014
There is growing demand for GM crops in the Agriculture industry across the world. Synthetic biology can also be used to develop crops with desirable traits such as salt-tolerance, drought-tolerance, and pest-resistance. The use of synthetic biology technologies facilitates the designing of GM crops with entirely new metabolic pathways, physiological traits, and developmental control strategies. The need to improve crops is now increasing as plants are not only considered as food, but also as a source of renewable feedstocks. This trend is expected to increase growth in the Global Synthetic Biology market over the forecast period.
Analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018. According to the report, the growth of the Global Synthetic Biology market is driven by several factors. One of the main drivers in this market is increased R&D in synthetic biology. As synthetic biology enables the development of innovative products through gene manipulation, vendors and various other research organizations are increasingly investing in R&D, so that they can offer new products in the market.
The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.
Global Synthetic Biology Market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The report recognizes the following companies as the key players in the Global Synthetic Biology Market : Amyris Inc., E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG: biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, Cobalt Technologies, Evolva Holdings SA, Exxon Mobil Corp., GeneWorks Pty Ltd., Genomatica Inc., Gevo Inc., Ginkgo Bioworks, Green Biologics Ltd., New England Biolabs Inc., OriGene Technologies Inc., REG Life Sciences LLC, Royal DSM, Synthorx Inc.
Purchase Report @ http://www.sandlerresearch.org/purchase?rname=19657.
Key Market Driver
- Increased R&D in Synthetic Biology
Key Market Challenge
- Lack of Modularized Biological Parts
Key Market Trend
- Growing Demand for GM Crops
Further, the report states that one of the major challenges in the market is the lack of modularized biological parts. Lack of standardization and modularization of synthesized biological parts causes unpredictability in their function that poses a risk of the crash of the biological circuitry. Other major challenges in the market are ethical, biosafety, and biosecurity concerns.
Key Questions Answered in this Report
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Other Related Reports:
Global Cell Culture Market 2014-2018: Analysts forecast the Global Cell Culture market will grow at a CAGR of 10.27 percent over the period 2013-2018.
- Becton, Dickinson and Co.
- EMD Millipore
- GE Healthcare
- Lonza Group AG
- Sigma Aldrich Corp.
- Thermo Fisher Scientific Inc.
Global Genomics and Proteomics Analytical Instruments Market 2014-2018: The Global Genomics and Proteomics Analytical Instruments market can be divided into four segments: Chromatography, Polymerase Chain Reaction, Mass Spectrometry, and Next-generation Sequencing. This report covers the present scenario and the growth prospects of the Global Genomics and Proteomics Analytical Instruments market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of analytical instruments in the above four segments.
Global Metabolomics Market 2014-2018: Analysts forecast the Global Metabolomics market will grow at a CAGR of 24.26 percent over the period 2013-2018.
The Global Metabolomics market can be divided into eight segments: Mass Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, High Performance Liquid Chromatography, Metabolomics-on-a-chip, Fourier-Transform Infrared Spectroscopy, Capillary Electrophoresis, and Electrochemical Array. These are the sets of methodologies and technologies that transform unstructured and structured data into meaningful and useful information processes.
Global Particle Size Analysis Market 2014-2018: The report covers the present scenario and the growth prospects of the Global Particle Size Analysis market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of particle size analyzers worldwide.
Sandlerresearch.org (http://www.sandlerresearch.org/) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.